Literature DB >> 8456543

Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside.

R Wang1, T R Higuera, S C Sikka, R K Minkes, J A Bellan, P J Kadowitz, F R Domer, W J Hellstrom.   

Abstract

The use of vasoactive intestinal peptide (VIP), sodium nitroprusside (SNP), and the reference combination of papaverine, prostaglandin E1, and phentolamine was studied in 22 adult cats. The maximal erectile response (intracavernous pressure, penile length, and rigidity) was produced by intracavernous injection of a combination of 1.65 mg papaverine, 0.5 micrograms PGE1, and 25 micrograms phentolamine. This combination was considered as "control" in order to compare the effect of other agents. VIP and SNP increased the intracavernous pressure and caused erection in a dose-dependent manner with a maximal response obtained with 5 micrograms VIP or 10 micrograms SNP. The duration of peak erection and the total duration of drug effect were significantly shorter with VIP and SNP than with the reference combination (P < 0.01). Epinephrine (30 micrograms) reversed the effects of SNP and significantly shortened the duration of peak action and total effect (P < 0.05). This study supports the use of an in vivo feline model for the evaluation of vasoactive agents and demonstrates that the intracavernous injection of either VIP or SNP can induce penile erection in the adult cat.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8456543     DOI: 10.1007/bf00295198

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  14 in total

1.  Potassium channel agonists cause penile erection in cats.

Authors:  Wayne J G Hellstrom; Run Wang; Philip J Kadowitz; Floyd R Domer
Journal:  Int J Impot Res       Date:  1992       Impact factor: 2.896

Review 2.  Vasoactive intracavernous pharmacotherapy.

Authors:  A A Sidi
Journal:  Urol Clin North Am       Date:  1988-02       Impact factor: 2.241

Review 3.  Local control of penile erection. Nerves, smooth muscle, and endothelium.

Authors:  I Saenz de Tejada; I Goldstein; R J Krane
Journal:  Urol Clin North Am       Date:  1988-02       Impact factor: 2.241

4.  Physiology of erection and pharmacological management of impotence.

Authors:  T F Lue; E A Tanagho
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

5.  Intracavernous injection of papaverine for erectile failure.

Authors:  R Virag
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

Review 6.  Risk factors for papaverine-induced priapism.

Authors:  G M Lomas; J P Jarow
Journal:  J Urol       Date:  1992-05       Impact factor: 7.450

7.  Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure.

Authors:  R Virag; D Frydman; M Legman; H Virag
Journal:  Angiology       Date:  1984-02       Impact factor: 3.619

8.  Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence.

Authors:  G S Brindley
Journal:  Br J Psychiatry       Date:  1983-10       Impact factor: 9.319

9.  Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.

Authors:  E A Kiely; S R Bloom; G Williams
Journal:  Br J Urol       Date:  1989-08

10.  Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1, and saline in primates.

Authors:  S R Aboseif; J Breza; R J Bosch; F Benard; C G Stief; W Stackl; T F Lue; E A Tanagho
Journal:  J Urol       Date:  1989-08       Impact factor: 7.450

View more
  1 in total

Review 1.  Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings.

Authors:  K E Andersson; F Holmquist
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.